Work

P1.03-026 Interim Results of a Phase I Study of Nivolumab plus Nab-Paclitaxel/Carboplatin in Patients with NSCLC

Year: 2017

Type: article

Study design: Clinical Trial

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2017.09.830

Authors: J.W. Goldman, D. Waterhouse, B. George, P. O'Dwyer, T. Chen, N. Trunova, K. Kelly

Institutions: University of California, Los Angeles, Oncology Hematology Care, Medical College of Wisconsin, Abramson Cancer Center, University of Pennsylvania, Celgene (United States), UC Davis Comprehensive Cancer Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2767678023

FWCI:

Cites:

Cited by:

Related to: 10